| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.17 | 0.007 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.008 |